3X4 Genetics and Rupa Health Partnership Aims to Bridge the Gap Between Genetic Science and Clinical Practice

SEATTLE, Oct. 31, 2024 /PRNewswire/ — 3X4 Genetics, a global leader in genetic testing, is proud to announce an exciting new development in their partnership with Rupa Health, a renowned provider of integrative healthcare solutions. The partnership provides healthcare professionals and patients the ability to harness the power of genetic information for more personalized and holistic care.

Throughout this strategic alliance, 3X4 Genetics and Rupa Health aim to bridge the gap between genetic science and clinical practice. By combining 3X4 Genetics’ technologically advanced genomic insights with Rupa Health’s innovative diagnostic platform, healthcare practitioners will be better equipped to deliver customized treatment plans tailored to each patient’s unique needs. The collaboration will allow doctors and healthcare professionals to access genetic data alongside comprehensive testing services, improving health outcomes, and empowering patients to make more informed decisions.

“Our collaboration with Rupa Health allows us to push the boundaries of what personalized healthcare can achieve. At 3X4 Genetics, we’ve always believed in the potential of genomic science to transform health, and with Rupa Health’s expertise in diagnostics and patient care, we can now accelerate that vision. Together, we are building a future where genetic insights lead to more precise and proactive care for all,” says Dr. Yael Joffe, the Chief Scientific Officer and founder of 3X4 Genetics.

By connecting their software, both companies ensure that healthcare remains adaptive, dynamic, and patient-centered.”Having this report on Rupa is an incredible resource for practitioners to better support their patients with complex genetic outcomes,” shares Tara Viswanathan, CEO and founder of Rupa Health.

By emphasizing the power of genetic testing to guide more effective, personalized health interventions, the partnership between 3X4 Genetics and Rupa Health is set to redefine how healthcare professionals approach patient care.

About 3X4 Genetics
3X4 Genetics is at the forefront of genetic testing and insights, empowering healthcare practitioners and individuals to harness the power of genetics to optimize health and well-being. With a focus on integrative and personalized healthcare, 3X4 Genetics uses cutting-edge genomic science to provide actionable health insights. For more information, visit www.3x4genetics.com.

About Rupa Health
Rupa Health is on a mission to bring root-cause medicine to every person on the planet. By simplifying the process of ordering, managing and interpreting diagnostic tests, Rupa helps practitioners identify and address the underlying factors that contribute to illness, empowering them to deliver personalized, data-driven, and holistic care. Rupa also brings the latest root cause medicine insights and offers modern patient experience. For more information, visit Rupahealth.com.

Contact Information: info@3x4genetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/3×4-genetics-and-rupa-health-partnership-aims-to-bridge-the-gap-between-genetic-science-and-clinical-practice-302293458.html

SOURCE 3×4 Genetics

Staff

Recent Posts

Optimal Breathing Holds its Annual Black Friday Sale

Turbo Oxygen EWOt System with 900 Liter Oxygen Reservoir Bag and Patented Mega-Flow Mask with…

6 hours ago

Nihon Kohden Introduces First-Ever ATO-Certified Ventilators

IRVINE, Calif.--(BUSINESS WIRE)--#RespiratoryCare--Nihon Kohden, a global leader in medical technology, today announced the introduction of…

21 hours ago

2025 Medicare Physician Fee Schedule Final Rule Includes Two Major Wins for Therapy Providers

APTA advocacy leads to impactful policy wins that will reduce administrative burden, improve access, and…

21 hours ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., Nov. 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical…

21 hours ago

Gestalt and Paige Partner to Enhance Digital Pathology Workflows with Integration of Advanced AI Algorithms

SPOKANE, Wash. and NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Gestalt, a leader in digital pathology…

21 hours ago

Wasatch BioLabs and Oxford Nanopore Team Up to Accelerate Methylation Sequencing Towards Clinical Use

SALT LAKE CITY and OXFORD, United Kingdom, Nov. 1, 2024 /PRNewswire/ -- Wasatch Biolabs (WBL),…

21 hours ago